These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15178731)

  • 1. Comment: therapy switching in patients receiving long-acting opioids.
    Jaderholm PL
    Ann Pharmacother; 2004; 38(7-8):1324-5; author reply 1325. PubMed ID: 15178731
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment: therapy switching in patients receiving long-acting opioids.
    White R
    Ann Pharmacother; 2004 Oct; 38(10):1752-3; author reply 1753. PubMed ID: 15340135
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: systematic review of long-acting oral opioids.
    Manchikanti L; Boswell MV; Atluri S
    J Pain Symptom Manage; 2004 Sep; 28(3):194-5; author reply 195. PubMed ID: 15336326
    [No Abstract]   [Full Text] [Related]  

  • 4. [Opioids in pain therapy: what role do costs play?].
    Müller-Schwefe G
    Krankenpfl J; 2005; 43(7-10):203. PubMed ID: 16515274
    [No Abstract]   [Full Text] [Related]  

  • 5. Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany.
    Greiner W; Lehmann K; Earnshaw S; Bug C; Sabatowski R
    Eur J Health Econ; 2006 Dec; 7(4):290-6. PubMed ID: 16983521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Situational administration of analgesics. Modern dosage forms for opioids].
    Bartholomäus J
    Pharm Unserer Zeit; 2002; 31(1):74-81. PubMed ID: 11852660
    [No Abstract]   [Full Text] [Related]  

  • 7. Influences of attitudes on family physicians' willingness to prescribe long-acting opioid analgesics for patients with chronic nonmalignant pain.
    Nwokeji ED; Rascati KL; Brown CM; Eisenberg A
    Clin Ther; 2007; 29 Suppl():2589-602. PubMed ID: 18164924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-release opioids for the management of chronic non-malignant pain.
    Sloan P; Babul N
    Expert Opin Drug Deliv; 2006 Jul; 3(4):489-97. PubMed ID: 16822224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pain--still the stepchild of therapy?].
    Müller-Schwefe G
    Krankenpfl J; 2005; 43(1-3):18-9. PubMed ID: 15912814
    [No Abstract]   [Full Text] [Related]  

  • 10. [Opioids for chronic pain patients. What are the consequences of following the Nordic recommendations?].
    Handberg G; Bendiksen A; McGehee E; Vrads R
    Ugeskr Laeger; 2007 Oct; 169(41):3486-8. PubMed ID: 17967279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Controlling tumor pain with delayed-action opioids. Better quality of life with effective pain treatment].
    MMW Fortschr Med; 2004 Apr; 146(17):48-9. PubMed ID: 15224907
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    Manchikanti L; Manchikanti KN; Pampati V; Cash KA
    Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment: Oral oxymorphone for pain management.
    Ahdieh H; White R
    Ann Pharmacother; 2007 Dec; 41(12):2074. PubMed ID: 17971405
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-acting opioids and short-acting opioids: appropriate use in chronic pain management.
    Fine PG; Mahajan G; McPherson ML
    Pain Med; 2009 Jul; 10 Suppl 2():S79-88. PubMed ID: 19691687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
    O'Connor AB; Zwemer FL; Hays DP; Feng C
    Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
    Ward A; Bozkaya D; Fleischmann J; Dubois D; Sabatowski R; Caro JJ
    Curr Med Res Opin; 2007 Oct; 23(10):2333-45. PubMed ID: 17697453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of long-acting opioid use and oral versus transdermal route among older Medicaid beneficiaries.
    Rigler SK; Shireman TI; Kallenbach L
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):91-9. PubMed ID: 17719511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of extended-release opioid analgesic formulations in the treatment of chronic pain.
    Nicholson B
    Pain Pract; 2009; 9(1):71-81. PubMed ID: 19019047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.